FDA took months to react to complaint about Abbott infant formula factory, audit finds

FILE - A sign at an Abbott Laboratories campus facility is displayed, April 28, 2016, in Lake Forest, Ill. A report released on Thursday, June 13, 2024, says the U.S. Food and Drug Administration took more than 15 months to act on a whistleblower complaint it received about conditions at an Abbott Nutrition factory that was at the center of a nationwide shortage of infant formula. (AP Photo/Nam Y. Huh, File)

The U.S. Food and Drug Administration took more than 15 months to act on a whistleblower complaint it received about conditions at an Abbott Nutrition factory that was at the center of a nationwide shortage of infant formula, a new audit shows.

The Department of Labor received the email and three days later forwarded it to an FDA address specifically for such complaints. But one of several staff members charged with managing the FDA inbox at the time “inadvertently archived†the email in February 2021, and it wasn’t found until a reporter requested it in June 2022.

The ´ºÉ«Ö±²¥ Press. All rights reserved.

More Health Stories

Sign Up to Newsletters

Get the latest from ´ºÉ«Ö±²¥News in your inbox. Select the emails you're interested in below.